Detalles de la búsqueda
1.
Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry.
Br J Dermatol
; 190(3): 355-363, 2024 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37846976
2.
Clinicopathological characteristics of cutaneous and mucocutaneous leishmaniasis in patients treated with TNF-α inhibitors.
J Dtsch Dermatol Ges
; 21(5): 473-480, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37042124
3.
Effectiveness and safety of guselkumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group.
Dermatol Ther
; 35(2): e15231, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34820971
4.
Fast and sustained improvement of patient-reported outcomes in psoriatic patients treated with secukinumab in a daily practice setting.
Dermatol Ther
; 35(8): e15653, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35731640
5.
Secukinumab is effective and safe in the long-term treatment of plaque psoriasis in a daily practice setting: Multicenter study in 384 Spanish patients.
Dermatol Ther
; 35(12): e15929, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36223184
6.
DNA Copy Number Variation Associated with Anti-tumour Necrosis Factor Drug Response and Paradoxical Psoriasiform Reactions in Patients with Moderate-to-severe Psoriasis.
Acta Derm Venereol
; 101(5): adv00448, 2021 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33846759
7.
Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
Acta Derm Venereol
; 101(1): adv00354, 2021 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33269405
8.
Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry.
J Am Acad Dermatol
; 83(1): 139-150, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32213306
9.
A prospective multicenter study assessing effectiveness and safety of secukinumab in a real-life setting in 158 patients.
J Am Acad Dermatol
; 81(2): 427-432, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30872150
10.
Treatment of palmoplantar psoriasis with oral roflumilast: a case series.
Clin Exp Dermatol
; 2024 Jun 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38921056
11.
Klinisch-pathologische Eigenschaften kutaner und mukokutaner Leishmaniose bei mit TNF-α-Inhibitoren behandelten Patienten.
J Dtsch Dermatol Ges
; 21(5): 473-481, 2023 05.
Artículo
en Alemán
| MEDLINE | ID: mdl-37183744
12.
Differences in epidemiology, comorbidities and treatment choice between plaque psoriasis and pustular psoriasis: results from the BIOBADADERM registry.
Br J Dermatol
; 187(5): 817-820, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35819180
13.
Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting.
J Am Acad Dermatol
; 87(3): 705-709, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35640798
14.
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis.
J Am Acad Dermatol
; 84(2): 513-517, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33122022
15.
The risk of urinary tract infections in patients with psoriasis on systemic medications in Biobadaderm Registry: A prospective cohort study.
J Am Acad Dermatol
; 82(3): 738-741, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31306726
16.
Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group.
Int J Dermatol
; 2024 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38736107
17.
Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting.
Int J Dermatol
; 63(4): 503-511, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38168847
18.
Drug survival and safety of biosimilars and originator adalimumab in the treatment of psoriasis: a multinational cohort study.
BMJ Open
; 13(7): e075197, 2023 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37451726
19.
Acute Necrotic Plaque in an Immunocompromised Host.
Am J Dermatopathol
; 39(5): e60-e61, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28426490
20.
Acute Necrotic Plaque in an Immunocompromised Host.
Am J Dermatopathol
; 39(5): 369, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26909588